申请人:Ates Celal
公开号:US20060183903A1
公开(公告)日:2006-08-17
The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds.
本发明涉及式(I)的新对映体纯哌嗪衍生物(其中 Y 代表羟基或离去基团,n 为 1、2、3、4 或 5),以及它们作为合成中间体的用途,特别是用于制备具有药用活性的化合物。